Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02577237 · ClinicalTrials.gov registry record · NA

Building Caregiver Skills Using a Simulation-based Intervention for Care of Head and Neck Cancer

A NA study, sponsored by Case Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
18
Enrollment target

NCT02577237: Completed NA study, sponsored by Case Comprehensive Cancer Center.

NCT02577237 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02577237, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target

Study Summary

Patients with head and neck cancer and their caregivers face many challenges. These include learning about cancer and its treatment, coping with symptoms from illness and treatment side effects, making adjustments to usual activities, and managing the emotional effects of having a serious illness. This study tests whether different forms of education and support can help family caregivers feel better prepared. To find out if education about caregiving and different kinds of support are effective, this study wants to compare approaches.One group includes caregivers who will receive an education and support program throughout radiation treatment in addition to usual care by their doctors and nurses. The other group receives an educational booklet about caregiving in addition to usual care by their doctors and nurses. The caregiver also completes surveys about his or her emotions, distress, confidence as a care giver, and quality of life. In addition, the study asks the caregiver questions about his or her age, race, ethnicity, marital status, employment status, education, annual household income, and current living arrangements. This pilot study will only be offered at the Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Main Campus.

Primary Outcome

Summary statistics as well as observed values of longitudinally measured efficacy outcome variables (efficacy for caregiving, anxiety, depression, and HRQOL) will be presented graphically. Linear mixed models will be used to estimate within- and between-subject components of variance needed for design of a larger trial with these endpoints.

Interventions

  • OTHER Interview
  • OTHER Survey
  • BEHAVIORAL In-person education sessions
  • BEHAVIORAL NCI Booklet

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2015-08-01
Est. Completion 2018-01-12
Phase NA
Case Comprehensive Cancer Center

407 total trials

What the finished NCT02577237 record still lists

NCT02577237 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 4 interventions - of which Interview is the first listed.

NCT02577237 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02577237 about?

NCT02577237 is a clinical study titled "Building Caregiver Skills Using a Simulation-based Intervention for Care of Head and Neck Cancer". Patients with head and neck cancer and their caregivers face many challenges. These include learning about cancer and its treatment, coping with symptoms from illness and treatment side effects, making adjustments to usual activities, and managing the emotional effects of having a serious illness. T...

What is the current status of trial NCT02577237?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2015-08-01. Estimated completion is 2018-01-12.

What interventions are being tested in trial NCT02577237?

The interventions under investigation include: Interview (OTHER), Survey (OTHER), In-person education sessions (BEHAVIORAL), NCI Booklet (BEHAVIORAL).

Who is sponsoring clinical trial NCT02577237?

This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02577237's enrollment target sits among peer trials

18 1863rd of 2000 higher than 130 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02577237, the US trial registry maintained by the National Library of Medicine. NCT02577237 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.